- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor Which conditions qualify? The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis in America Medical Cannabis Access for Pain Treatment
- News News
- Join Join
Fact Sheet on ASA's Data Quality Act Petition to HHS
This article is available for download in .PDF format (66K)
Americans for Safe Access (ASA) has filed a legal petition with the U.S. Department of Health and Human Services (HHS) to correct misinformation about the medical use of cannabis. ASA's petitionuses the provisions of the Data Quality Act to ask HHS to change its public statements about cannabis to reflect current scientific understanding and medical practice.
What is the Data Quality Act?
The Data Quality Act (DQA) requires federal agencies to use reliable science when making regulations and disseminating information. Specifically, the DQA requires that the information circulated by federal agencies is fair, objective, and meets certain quality guidelines. It also permits citizens to challenge government information believed to be inaccurate or based on faulty, unreliable data. Business, consumer, environmental and conservation groups have all used the DQA to pursue changes in federal policy.
What is ASA's Challenge to the DQA?
The Department of Health and Human Services (HHS) is a significant roadblock for a variety of issues impacting medical cannabis patients. HHS obstructs research, maintains a monopoly over the supply of cannabis and funds that could be used for medical research, and they control the process for rescheduling cannabis.
In 2001, HHS published information in the Federal Register concerning a previous petition to reclassify cannabis. ASA believes the "information" HHS provided was inaccurate and did not consider all the scientific evidence available. Our petition requests the following corrections be made to the HHS and FDA websites in addition to the Federal Registry:
|1.||"There have been no studies that have scientifically assessed the efficacy of marijuana for any medical condition,"||Replaced with: "Adequate and well-recognized studies show the efficacy of marijuana in the treatment of nausea, loss of appetite, pain and spasticity."|
|2.||"A material conflict of opinion among experts precludes a finding that marijuana has been accepted by qualified experts" and "it is clear that there is not a consensus of medical opinion concerning medical applications of marijuana,"||Replaced with: "There is substantial consensus among experts in the relevant disciplines that marijuana is effective in treating nausea, loss of appetite, pain and spasticity. It is accepted as medicine by qualified experts."|
|3.||"A complete scientific analysis of all the chemical components found in marijuana has not been conducted,"||Replaced with: "The chemistry of marijuana is known and reproducible."|
|4.||"[Marijuana] has no currently accepted medical use in treatment in the United States,"||Replaced with: "Marijuana has a currently accepted use in treatment in the United States."|
How does this Petition Help Patients and Doctors?
The debate about medical cannabis is at a gridlock due to federal government intransigence. The public, along with doctors, scientists, and patients, all know that cannabis therapies benefit millions in the US, while the federal government refuses to budge from its claim that "marijuana has no accepted medical value." ASA's challenge under the DQA highlights the government's unwillingness to recognize overwhelming evidence of marijuana's medical value, and forces the federal Department of Health and Human Services to reconsider their erroneous position. In so doing, ASA intends to break through the gridlock and advance the dialog on medical cannabis so that further research can be conducted, and a federal policy can be established that respects the rights and needs of patients. Ultimately, ASA seeks to end the current harm inflicted on patients as a result of misguided federal policy, which prioritizes politics over science.